Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.15 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |